Troubled Unum rebrands as Cogent Biosciences, replaces CEO Chuck Wilson with Andrew Robbins; Jennifer Fox appointed as CFO at David Hung-led Nuvation Bio

Andrew Robbins

? Rife with turmoil and hit with a barrage of FDA holds as it spiraled into penny-stock territory, Unum Therapeutics hopes a new name — Cogent Biosciences — and a new CEO can turn its fortunes around. Andrew Robbins

Click to view original post

Advertise With Us